comparemela.com

Latest Breaking News On - Affinity asset advisors - Page 1 : comparemela.com

Rezolute, Inc. (NASDAQ:RZLT) Sees Large Increase in Short Interest

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 814,600 shares, a growth of 162.0% from the May 15th total of 310,900 shares. Based on an average daily trading volume, of 571,100 shares, […]

United-states
Daron-evans
Craig-hallum
Rosalind-advisors-inc
Vanguard-group-inc
Virtu-financial
Acadian-asset-management
Affinity-asset-advisors
Securities-exchange-commission
Rezolute-inc
Nasdaq
Maxim-group

Kura Oncology (NASDAQ:KURA) Trading Down 4.7%

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) dropped 4.7% during trading on Monday . The stock traded as low as $20.43 and last traded at $20.73. Approximately 262,616 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 1,133,167 shares. The stock had previously closed at $21.76. Analyst […]

Teresa-brophy-bair
Pricet-rowe-associates-inc
Nasdaq
Avoro-capital-advisors
Artal-group
Affinity-asset-advisors
Platinum-investment-management-ltd
Kura-oncology-inc
Kura-oncology
Get-free-report
Capital-advisors
Asset-advisors

Point72 Asset Management L.P. Boosts Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Point72 Asset Management L.P. raised its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,756,122 shares of the biopharmaceutical company’s stock after acquiring an additional 1,413,722 shares during the […]

Wellington
New-zealand-general
New-zealand
Elizabeth-crowley
Dianec-young
Affinity-asset-advisors
Celldex-therapeutics-inc
Bellevue-group
Exchange-commission
Eventide-asset-management
Celldex-therapeutics
Wellington-management-group

Point72 Asset Management L.P. Acquires 1,413,722 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Point72 Asset Management L.P. lifted its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,756,122 shares of the biopharmaceutical company’s stock after purchasing an additional 1,413,722 shares during the period. Point72 Asset Management L.P. […]

Wellington
New-zealand-general
New-zealand
Elizabeth-crowley
Richardm-wright
Dekabank-deutsche-girozentrale
Wolfe-research
Cantor-fitzgerald
Nasdaq
Wellington-management-group
Celldex-therapeutics
Celldex-therapeutics-inc

Bellevue Group AG Raises Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […]

United-states
Canada
Markl-jacobson
Mark-coleman
Robertw-baird
Wealth-group
Affinity-asset-advisors
Royal-bank
Citigroup
Axsome-therapeutics-inc
Exchange-commission
Td-asset-management-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.